United Biomedical Inc's Form 4 filing
Vaxxinity, Inc. (VAXX) · filed Apr 28, 2022
- Accession no.
- 0000899243-22-015866
- Filed
- Apr 28, 2022
- Trade date
- Apr 26-27, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $79.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| United Biomedical IncCIK 0000896839 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 26, 2022 | Class A common stock | PPurchaseAcquired | +18,105 | $3.45F2 | +$62,462.25 | 51,611,559 | Direct | Duplicate filing |
| Apr 27, 2022 | Class A common stock | PPurchaseAcquired | +4,807 | $3.58F2 | +$17,209.06 | 51,616,366 | Direct | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported is a weighted average price.
Referenced by the price of 2 transactions in Table I.